Cette liste est basée sur les listes de surveillance des personnes sur Stock Events qui suivent LQDA. Il ne s'agit pas d'une recommandation d'investissement.
Sur la base de 8 notations au cours des 6 derniers mois. Il ne s'agit pas d'une recommandation d'investissement.
Acheter
88%
Détenir
13%
Vendre
0%
À propos de nous
Health Technology
Pharmaceuticals: Major
Manufacturing
Medicinal and Botanical Manufacturing
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil injection in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.